12 January 2015
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs to treat cancer and viral disease, today announced the appointment of Dr Eliot Forster as Chief Executive Officer with immediate effect.
Please click on the link below to download the full Press Release:
Immunocore appoints Dr Eliot Forster as Chief Executive Officer
